An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes

PDA J Pharm Sci Technol. 2022 Nov-Dec;76(6):497-508. doi: 10.5731/pdajpst.2021.012662. Epub 2022 Jul 15.

Abstract

The identification of critical process parameters in biologics and small molecule process development is a key element of quality by design. The objectivity and consistency of procedures to identify critical process parameters can be improved with the use of impact ratios. Impact ratios quantify a process parameter's practical effect on a critical quality attribute relative to the critical quality attribute's acceptance limits. If the impact ratio is large, i.e., exceeds a predefined impact ratio threshold, the recommendation is to classify the process parameter as a critical process parameter. This article introduces an improved and mathematically well-defined impact ratio. Benefits of this impact ratio are a consistent interpretation for many scenarios commonly encountered in practice, high suitability to automation, and the possibility of standardizing on a single impact ratio definition for pharmaceutical manufacturing.

Keywords: Critical process parameter; Critical quality attribute; Critical quality attribute acceptance limits; Impact ratio; Impact ratio threshold.

MeSH terms

  • Biological Products*
  • Pharmaceutical Preparations
  • Technology, Pharmaceutical* / methods

Substances

  • Biological Products
  • Pharmaceutical Preparations